Search results

Careers

Collaborate. Contribute. Change lives.
https://www.oxb.com/careers

SAR 422459 (Sanofi)

SAR422459 Gene therapy for Stargardt disease

Licensed to Sanofi: Phase II ongoing

https://www.oxb.com/pipeline-items/sar-422459-sanofi

Stem Cell Meeting on the Mesa – California, October 2015

https://www.oxb.com/videos/stem-cell-meeting-mesa-california-october-2015

Interview with Oxford BioMedica's CEO, John Dawson

https://www.oxb.com/videos/interview-oxford-biomedicas-ceo-john-dawson

A short film featuring our bioprocessing facility

https://www.oxb.com/videos/short-film-featuring-our-bioprocessing-facility

Philippa Gardner

https://www.oxb.com/analysts/philippa-gardner

Martin Hall

https://www.oxb.com/analysts/martin-hall

SAR 421869 (Sanofi)

SAR 421869

Gene therapy for Usher syndrome type 1B

Licensed to Sanofi: Phase I/IIa trial ongoing

https://www.oxb.com/pipeline-items/sar-421869-sanofi

Peter Nolan talks at Stem Cell Meeting on the Mesa, California

https://www.oxb.com/videos/peter-nolan-talks-stem-cell-meeting-mesa-california

Emily Whitehead, the first child to be enrolled in CTL019

https://www.oxb.com/videos/emily-whitehead-first-child-be-enrolled-ctl019

Pages